Peak Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol

Summary

The objective of this study is to compare the peak dose relative bronchoprotection offered by levosalbutamol and racemic salbutamol in mild to moderate asthmatics preselected into two groups on the basis of their beta-2 adrenoreceptor polymorphisms.

Timeline

Start

2009-01

Primary completion

2010-01

Completion

2010-01

Drugs

Indications